Greater Regulation Of Pharma By Congress Could Be Risky – FDA’s Gottlieb
Executive Summary
The push on Capitol Hill to increase regulation of the pharmaceutical industry may be a dangerous trend, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb suggested